2016 - Contraceptive Technology Boston

Apr 24, 2016 ‐ Apr 27, 2016


Total CE Credits:
76.00 - Physician
76.00 - RN / NP (All RNs/Nurses except CA RNs)
76.00 - CA RN/CA BRN
19.50 - Pharmacology


The changing medical and policy climates continue to challenge reproductive health care providers, as we work at keeping our focus on providing high quality, evidence-based care for our patients. The 2016 online conference features current research as well as recent and future developments in contraceptive technology. You’ll learn how to develop strategies for approaching a variety of contraceptive management challenges, including adolescent issues, IUD complications, bleeding problems, and chronic medical conditions. Our outstanding faculty also addresses a variety of gynecologic conditions in women - vulvar disease, recurrent vaginitis and heavy menstrual bleeding. You’ll learn screening techniques along with clinical management of common and complex challenges in women's health and primary care, including STDs, obesity, sexual pharmacology, vulvar dermatology, depression and other current topics.

Program Manager:

Donna Brian PhD, CRNP
Consultant
Contemporary Forums

Disclosures: The Program Manager has nothing to disclose

Standard: $912.00

Sessions

Abnormal Uterine Bleeding: An Update in Terminology and Classification

Apr 24, 2016 8:00am ‐ Apr 24, 2016 8:15am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Explain the need to replace older terminology
  • List the differential to consider for women of different ages who present with heavy or prolonged bleeding
  • Describe the elements of the PALM-COEIN System

Speaker(s): Disclosures
  • Anita Nelson, MD:

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck, NIH
    Allergan, Agile, Aspen Pharma, Bayer, Merck
    Allergan, Agile, Bayer, ContraMed
    Female Health, Merck, MicroCHIPS Biotech
    PharmaNest

    Relationship:

    Research (Grants)
    Speakers Bureau/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria

Standard: $6.00

Nationally-Based Family Planning Guidelines: What Are They? How Do I Use Them?

Apr 24, 2016 8:00am ‐ Apr 24, 2016 8:30am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe three separate nationally-based guidelines available through the Centers for Disease Control and Prevention (CDC)
  • Identify point-of care-tools for use in clinical practice
  • Display familiarity with use of the MEC app and SPR e-book

Speaker(s): Disclosures
  • Patty Cason, MS, FNP-BC:

    Patty Cason, MSN, FNP-BC

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Robert Hatcher, MD, MPH:

    Robert Hatcher, MD, MPH

    Disclosures:

    This speaker has nothing to disclose

  • Melissa Kottke, MD, MPH:

    Melissa Kottke, MD, MPH, MBA

    Disclsoure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Emily Godfrey, MD, MPH

    Disclosure:

    Merck
    Merck
    Teva
    Bayer
    Prima-temp

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Standard: $12.00

Infrequent Bleeding and PCOS 2016 (Rx = .25 hr.)

Apr 24, 2016 8:15am ‐ Apr 24, 2016 9:15am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Review the differences among 3 criteria sets for the diagnosis of PCOS
  • List 5 conditions that can cause hirsuitism other than PCOS
  • List the 2 conditions for each of the letters in the PALM-COEIN acronym

Speaker(s): Disclosures
  • Anita Nelson, MD:

    Anita L. Nelson, MD

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck, NIH
    Allergan, Agile, Aspen Pharma, Bayer, Merck
    Allergan, Agile, Bayer, ContraMed
    Female Health, Merck, MicroCHIPS Biotech
    PharmaNest

    Relationship:

    Research (Grants)
    Speakers Bureau/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria

Standard: $18.00

U.S. Medical Eligibility Criteria: Using Guidance to Determine Safest Methods for Women with Medical Conditions (Rx = .75 hr.)

Apr 24, 2016 8:30am ‐ Apr 24, 2016 9:30am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe the classification scheme of the US MEC
  • Practice using different US MEC tools
  • Determine evidence-based contraceptive care for complex clinical scenarios using these tools

Speaker(s): Disclosures
  • Patty Cason, MS, FNP-BC:

    Patty Cason, MSN, FNP-BC

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Robert Hatcher, MD, MPH:

    Robert Hatcher, MD, MPH

    Disclosure:

    This speaker has nothing to disclose

  • Melissa Kottke, MD, MPH:

    Melissa Kottke, MD, MPH, MBA

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Emily Godfrey, MD, MPH

    Disclosure:

    Merck
    Merck
    Teva
    Bayer
    Prima-temp

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Standard: $18.00

Heavy Menstrual Bleeding (Rx = .25 hr.)

Apr 24, 2016 9:15am ‐ Apr 24, 2016 10:00am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • List the differential to consider for women of different ages who present with heavy or prolonged bleeding
  • Outline appropriate tests to evaluate them
  • Describe options to treat acute excessive and chronic heavy bleeding

Speaker(s): Disclosures
  • Anita Nelson, MD:

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck, NIH
    Allergan, Agile, Aspen Pharma, Bayer, Merck
    Allergan, Agile, Bayer, ContraMed
    Female Health, Merck, MicroCHIPS Biotech
    PharmaNest

    Relationship:

    Research (Grants)
    Speakers Bureau/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria

Standard: $15.00

U.S. Selected Practice Recommendations: What Does the Evidence Say About Handling Challenging or Controversial Contraceptive Management Questions? (Rx = .75 hr.)

Apr 24, 2016 9:30am ‐ Apr 24, 2016 10:15am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe the contents of US SPR and its intended use
  • Describe how to use the US SPR, including using any associated tools
  • Apply the guidance in specific situations, based on clinical scenarios

Speaker(s): Disclosures
  • Patty Cason, MS, FNP-BC:

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Melissa Kottke, MD, MPH:

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Disclosure:

    Merck
    Merck
    Teva
    Bayer
    Prima-temp

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Standard: $15.00

Infertility Workup and Early Management for the Generalist (Rx = .25 hr.)

Apr 24, 2016 10:15am ‐ Apr 24, 2016 11:00am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • List 5 causes of female infertility
  • List 5 causes of male infertility
  • Describe the step-by-step evaluation in the management of an infertile woman who is ovulating

Speaker(s): Disclosures
  • Anita Nelson, MD:

    .

Standard: $15.00

Quality Family Planning Services for Men: Do They Differ From Quality Services for Women? (Rx = .50 hr.)

Apr 24, 2016 10:30am ‐ Apr 24, 2016 11:15am
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Display familiarity with use of the Quality Family Planning app
  • Describe the steps in providing contraceptive services for males and females
  • List 5 principles of quality counseling

Speaker(s): Disclosures
  • Patty Cason, MS, FNP-BC: Patty Cason, MSN, FNP-BC

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Robert Hatcher, MD, MPH:

    Robert Hatcher, MD, MPH

    Disclosure:

    This speaker has nothing to disclose

  • Melissa Kottke, MD, MPH: Melissa Kottke, MD, MPH, MBA

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Emily Godfrey, MD, MPH

    Disclosure:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Standard: $15.00

Focus on Endocrinopathies Affecting Reproductive Health (Rx = .25 hr.)

Apr 24, 2016 11:00am ‐ Apr 24, 2016 12:15pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Describe how thyroid dysfunction, prolactin disorders and androgen excess can affect menstrual cycling and fertility
  • Counsel women about how diabetes can affect reproductive health and pregnancy outcomes
  • Explain how menstrual disorders affect risks for carcinoma

Speaker(s): Disclosures
  • Anita Nelson, MD:

    Disclosure:

    Agile Pharmaceutical, ContraMed, Merck, NIH
    Allergan, Agile, Aspen Pharma, Bayer, Merck
    Allergan, Agile, Bayer, ContraMed
    Female Health, Merck, MicroCHIPS Biotech
    PharmaNest

    Relationship:

    Research (Grants)
    Speakers Bureau/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria
    Consultant/Advisory Board/Honoraria

Standard: $21.00

Interesting Cases Using U.S. National Contraceptive Guidelines (Rx = .25 hr.) - Q&D (Rx = .25 hr.) - Faculty Panel

Apr 24, 2016 11:15am ‐ Apr 24, 2016 12:15pm
Expiration Date: May 12, 2019

Credits: None available.

Learning Objectives:

  • Integrate MEC, SPR, and QFP into every day cases with patients
  • Discuss how to combine the tools related to MEC, SPR, and QFP in clinical setting

Speaker(s): Disclosures
  • Patty Cason, MS, FNP-BC: Patty Cason, MSN, FNP-BC

    Disclosure:

    Merck
    Teva
    Actavis, Medicines 360
    Bayer
    ContraMed
    Evofem

    Relationship:

    Trainer Speaker Advisory Board
    Consultant
    Trainer Speaker
    Consultant, Advisory Board
    Consultant, Trainer
    Advisory Board

  • Robert Hatcher, MD, MPH:

    Robert Hatcher, MD, MPH

    Disclosure:

    This speaker has nothing to disclose

  • Melissa Kottke, MD, MPH: Melissa Kottke, MD, MPH, MBA

    Disclosure:

    Merck
    CSL Behring

    Relationship:

    Faculty Trainer
    Consultant

  • Emily Godfrey, MD, MPH:

    Emily Godfrey, MD, MPH

    Disclosure:

    Merck
    Merck
    Teva
    Bayer
    Prima-temp

    Relationship:

    Trainer
    Research
    Research
    Research
    Research

Standard: $18.00
Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content